p53 Mutation decreased radiosensitivity in rat yolk sac tumor cell lines

International Journal of Radiation Oncology Biology Physics

Volumn 44, Issue 3, 1999, Pages 677-682

  Maebayashi, Katsuya ^a   Mitsuhashi, Norio ^a   Takahashi, Takeo ^a   Sakurai, Hideyuki ^a   Niibe, Hideo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Immunoblot analysis; p53 tumor suppressor gene; PCR SSCP; Radiosensitivity; Rat yolk sac tumor

Indexed keywords

PROTEIN P53;

ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; RAT; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE; YOLK SAC TUMOR;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENDODERMAL SINUS TUMOR; GENES, P53; IMMUNOBLOTTING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; RATS; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032999509     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00025-5     Document Type: Article

References (34)

1. Nozaki M. Biological and histological characteristics of experimental yolk sac tumor developed by fetectomy and their usefulness in radiotherapeutic experiments. J Jpn Soc Ther Radiat Oncol. 4:1992;33-43.
2. Mitsuhashi N., Takahashi T., Nozaki M., et al. Establishment and characterization of a rat yolk sac tumour cell line, NMT-1, producing alpha-fetoprotein, with potential for lymphatic metastasis. Jpn J Cancer Res. 84:1993;1287-1291.
3. Mitsuhashi N., Takahashi T., Sakurai H., et al. A radioresistant variant cell line, NMT-1R, isolated from a radiosensitive rat yolk sac tumour cell line, NMT-1: Differences of early radiation-induced morphological changes, especially apoptosis. Int J Radiat Biol. 69:1996;329-336.
4. Mitsuhashi N., Ishikawa H., Saito Y., et al. A quantitative study of radiation-induced apoptosis in two rat yolk sac tumour cell lines with different radiosensitivities in vitro. Anticancer Res. 17:1997;3605-3608.
5. Nakamoto S., Mitsuhashi N., Takahashi T., et al. An interaction of cis-platin and radiation in two rat yolk sac tumour cell lines with different radiosensitivities in vitro. Int J Radiat Biol. 70:1996;747-753.
6. Saito Y., Mitsuhashi N., Takahashi T., et al. Cytotoxic effect of paclitaxel (taxol) either alone or in combination with irradiation in two rat yolk sac tumour cell lines with different radiosensitivities in vitro. Int J Radiat Biol. 73:1998;225-231.
7. Su L.N., Little J.B. Transformation and radiosensitivity of human diploid skin fibroblast transfected with SV40 T-antigen mutants defective in RB and p53 biding domains. Int J Radiat Biol. 62:1992;461-468.
8. Siles E., Villalobos M., Valenzuela M.T., et al. Relationship between p53 status and radiosensitivity in human tumor cell lines. Br J Cancer. 73:1996;581-588.
9. Yount G.L., Haas-Kogan D.A., Vidair D.A., et al. Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells. Cancer Res. 56:1996;500-506.
10. Langley R.E., Quartuccio S.G., Kennealey P.T., et al. Effect of cell cycle stage, dose rate and repair of sublethal damage on radiation-induced apoptosis in F9 teratocarcinoma cells. Radiat Res. 144:1995;90-96.
11. Lutzker S.G., Levine A.J. A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nature Med. 2:1996;804-810.
12. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
13. Makino H., Ushijima T., Kakiuchi H., et al. Absence of p53 mutation in rat colon tumors induced by 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole, 2-amino-3methylimidazo[4,5-f]quinoline or 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn J Cancer Res. 85:1994;510-514.
14. Ushijima T., Makino H., Nakayasu M., et al. Presence of p53 mutation in 3Y1-B clone 1-6: A rat cell line widely used as a normal immortalized fibroblast. Jpn J Cancer Res. 85:1994;455-458.
15. Suzui M., Yoshimi N., Tanaka T., et al. Infrequent Ha-ras mutations and absence of Ki-ras, N-ras, and p53 mutations in 4-nitroquinoline 1-oxide-induced rat oral lesions. Mol Carcinog. 14:1995;294-298.
16. Suzui M., Yoshimi N., Ushijima T., et al. No involvement of Ki-ras or p53 gene mutations in colitis-associated rat colon tumors induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate. Mol Carcinog. 12:1995;193-197.
17. Hulla J.E., Schneider R.P. Structure of the rat p53 tumor suppressor gene. Nucleic Acids Res. 21:1993;713-717.
18. Yamada J., Kuramoto T., Serikawa T. A rat genetic linkage map and comparative maps for mouse or human homologous rat genes. Mamm Genome. 5:1994;63-83.
19. Orita M., Iwahana H., Kanazawa H., et al. Detection of polymorphysms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA. 86:1989;2766-2770.
20. Levine A.J., Momand J., Finlay C.A. The p53 tumor suppressor gene. Nature. 6:1991;453-456.
21. Brachman D.G., Beckkett M., Graves D., et al. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res. 53:1993;3667-3669.
22. Biard D.S.F., Martin M., Le Rhun Y., et al. Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. Cancer Res. 54:1994;3361-3364.
23. McIlwrath A.J., Vasey P.A., Ross G.M., et al. Cell cycle arrests and radiosensitivity of human tumor cell lines Dependence on wild-type p53 for radiosensitivity . Cancer Res. 54:1994;3718-3722.
24. Pardo F.S., Su M., Borek C., et al. Transfection of rat embryo cells with mutant p53 increases the intrinsic radiation resistance. Radiat Res. 140:1994;180-185.
25. Zhen W., Denault C.M., Loviscek K., et al. The relative radiosensitivity of TK6 and WI-L2-NS lymphoblastoid cells derived from a common source is primarily determined by their p53 mutational status. Mutat Res. 346:1995;85-92.
26. Wu X., Bayle J.H., Olson D., et al. The p53-mdm-2 autoregulatory feedback loop. Gene Dev. 7:1993;1126-1132.
27. Wang Y., Ramqvist T., Szekely Y., et al. Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line. Cell Growth Differ. 4:1993;467-473.
28. Hayashi K. PCR-SSCP A simple and sensitive method for detection of mutations in the genomic DNA . PCR Methods Appl. 1:1991;34-38.
29. Hayashi K., Yandell D.W. How sensitive is PCR-SSCP? Hum Mutat. 2:1993;338-346.
30. Miyashita T., Krajewski S., Krajewski M., et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1994;1799-1805.
31. Isaacs Js., Chiao C., Merrick Ba., et al. p53-dependent p21 induction following gamma-irradiation without concomitant p53 induction in a human peripheral neuroepithelioma cell line. Cancer Res. 57:1997;2986-2992.
32. Findley Hw., Gu L., Yeager Am., et al. Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood. 89:1997;2986-2993.
33. Iwadate Y., Fujimoto S., Tagawa M., et al. Association of p53 gene mutation with decreased chemosensitivity in human malignant gliomas. Int J Cancer. 69:1996;236-240.
34. Gan Y., Wientjes M.G., Schuller D.E., et al. Pharmacodynamics of taxol in human head and neck tumor. Cancer Res. 56:1996;2086-2093.